UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C. 20549
                           FORM 10-QSB
(Mark One)

[X]                          QUARTERLY REPORT PURSUANT TO
                             SECTION 13 OR 15(d) OF THE
                             SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: March 31, 2003

Or

[ ]                          TRANSITION REPORT PURSUANT TO
                             SECTION 13 OR 15(d) OF THE
                             SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to _____________

Commission File Number: 000-33187

                    CareDecision Corporation
                    ------------------------
     (Exact name of registrant as specified in its charter)

             Nevada                            91-2105842
             ------                            ----------
 (State or other jurisdiction of  (I.R.S. Employer Identification No.)
  incorporation or organization)

     2 Penn Plaza, 15th Floor, Suite               10121
          1500-53, New York, NY                    -----
     -------------------------------             (Zip Code)
 (Address of principal executive offices)

                         (212) 292-4959
                         --------------
      (Registrant's telephone number, including area code)

------------------------------------------------------------------
 (Former name, former address and former fiscal year, if changed
                       since last report)

 Indicate by check mark whether the registrant (1) has filed all
   reports required to be filed by Section 13 or 15(d) of the
 Securities Exchange Act of 1934 during the preceding 12 months
 (or for such shorter period that the registrant was required to
   file such reports), and (2) has been subject to such filing
               requirements for the past 90 days.
                         Yes [X] No [ ]

  APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS
                DURING THE PRECEDING FIVE YEARS:
   Indicate by check mark whether the registrant has filed all
documents and reports required to be filed by Sections 12, 13 or
 15(d) of the Securities Exchange Act of 1934 subsequent to the
  distribution of securities under a plan confirmed by a court.
                         Yes [ ] No [ ]

              APPLICABLE ONLY TO CORPORATE ISSUERS:
The number of shares outstanding of each of the issuer's classes
     of common stock as of the most recent practicable date:
                           83,364,137


/1/


                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)


                        Table of Contents

                                                                     Page
                                                                     ----
PART I - FINANCIAL INFORMATION

  Item 1. Financial Statements                                          3

     Independent Accountant's Review Report                             4

     Consolidated Balance Sheet March 31, 2003 (unaudited)              5

     Consolidated Statements of Operations For the Three Months         6
     Ended March 31, 2003 and 2002 (unaudited) and For the Period
     July 6, 2000 (Inception) to March 31, 2003 (unaudited)

     Consolidated Statements of Cash Flows For the Three Months         7
     Ended March 31, 2003 and 2002 (unaudited) and For the Period
     July 6, 2000 (Inception) to March 31, 2003 (unaudited)

     Notes to Financial Statements                                      8

  Item 2. Management's Discussion and Plan of Operation                11

PART II - OTHER INFORMATION

  Item 6. Exhibits                                                     14

SIGNATURES                                                             15

ATTACHMENT A - FORM OF CERTIFICATION FOR FORM 10-QSB                   16


/2/


                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)

                   Consolidated Balance Sheet
                              as of
                   March 31, 2003 (unaudited)

                               and

              Consolidated Statements of Operations
                   for the Three Months Ended
              March 31, 2003 and 2002 (unaudited),
                       and For the Period
     July 6, 2000 (Inception) to March 31, 2003 (unaudited)

                               and

              Consolidated Statements of Cash Flows
                   for the Three Months Ended
              March 31, 2003 and 2002 (unaudited),
                       and For the Period
     July 6, 2000 (Inception) to March 31, 2003 (unaudited)


/3/


Beckstead and Watts, LLP
Certified Public Accountants
                                          3340 Wynn Road, Suite B
                                              Las Vegas, NV 89102
                                                     702.257.1984
                                                 702.362.0540 fax


             INDEPENDENT ACCOUNTANT'S REVIEW REPORT

Board of Directors
CareDecision Corporation
(formerly ATR Search Corporation)
(a Development Stage Company)
New York, NY

We  have  reviewed the accompanying balance sheet of CareDecision
Corporation   (formerly   ATR  Search  Corporation)   (a   Nevada
corporation) (a development stage company) as of March  31,  2003
and  the  related  statements of operations for the  three-months
ended  March  31, 2003 and 2002 and for the period July  6,  2000
(Inception) to March 31, 2003, and statements of cash  flows  for
the three-months ended March 31, 2003 and 2002 and for the period
July  6,  2000  (Inception) to March 31, 2003.   These  financial
statements are the responsibility of the Company's management.

We conducted our reviews in accordance with standards established
by  the  American Institute of Certified Public  Accountants.   A
review  of interim financial information consists principally  of
applying  analytical  procedures to financial  data,  and  making
inquiries  of  persons responsible for financial  and  accounting
matters.   It  is  substantially less  in  scope  than  an  audit
conducted   in   accordance  with  generally  accepted   auditing
standards,  which will be performed for the full  year  with  the
objective  of  expressing  an  opinion  regarding  the  financial
statements taken as a whole.  Accordingly, we do not express such
an opinion.

Based   on  our  reviews,  we  are  not  aware  of  any  material
modifications  that should be made to the accompanying  financial
statements  referred to above for them to be in  conformity  with
generally accepted accounting principles in the United States  of
America.

The accompanying financial statements have been prepared assuming
the  Company  will continue as a going concern.  As discussed  in
Note  2  to the financial statements, the Company has had limited
operations  and  has not commenced planned principal  operations.
This raises substantial doubt about its ability to continue as  a
going concern.  Management's plans in regard to these matters are
also  described  in  Note  2.  The financial  statements  do  not
include  any  adjustments that might result from the  outcome  of
this uncertainty.

We  previously  audited,  in accordance with  generally  accepted
auditing standards, the balance sheet of CareDecision Corporation
(formerly  ATR Search Corporation) (a development stage  company)
as   of  December  31,  2002,  and  the  related  statements   of
operations,  stockholders' equity, and cash flows  for  the  year
then  ended (not presented herein) and in our report dated  April
4,  2003,  we expressed an unqualified opinion on those financial
statements.

/s/ Beckstead and Watts, LLP

May 13, 2003


/4/


                         CareDecision Corporation
                     [formerly ATR Search Corporation]
                       (a Development Stage Company)
                        Consolidated Balance Sheet
                                (unaudited)



                                                            March 31,
  Assets                                                      2003
                                                          -------------
     Current assets:
       Cash and equivalents                               $      81,032
       Notes receivable                                           3,464
                                                          -------------
          Total current assets                                   84,496
                                                          -------------

  Fixed assets, net                                             197,888

  Intellectual property, net                                  1,366,359

  Loan to officer                                                   388
                                                          -------------

                                                          $   1,649,131
                                                          =============

  Liabilities and Stockholders' Equity

     Current liabilities:
       Note payable to shareholder                        $      37,199
       Notes payable                                            506,830
                                                          -------------
          Total current liabilities                             544,029
                                                          -------------

  Convertible notes - related party                              50,000
                                                          -------------

                                                                594,029
                                                          -------------

  Stockholders' equity:
     Common stock, $0.001 par value, 200,000,000 shares
      authorized, 83,364,137 shares issued and outstanding       83,364
     Additional paid-in capital                3,450,089
     Treasury stock                            (96,750)
     (Deficit) accumulated during development stage          (2,381,601)
                                                          -------------
                                                              1,055,102
                                                          -------------

                                                          $   1,649,131
                                                          =============



The accompanying notes are an integral part of these financial statements.


/5/


                         CareDecision Corporation
                     [formerly ATR Search Corporation]
                       (a Development Stage Company)
                   Consolidated Statements of Operations
                                (unaudited)


                                For the three months ended     July 6,2000
                                        March 31,            (inception) to
                                --------------------------      March 31,
                                    2003          2002            2003
                                ------------  ------------   --------------

Revenue                         $        500  $          -   $        2,500
                                ------------  ------------   --------------

Expenses:
  General & administrative            38,878             -          121,564
   expenses
  Payroll expense                     58,881             -          245,700
  Professional fees                   30,570             -          202,422
  Consulting expense                 231,000             -        1,550,482
  Software development                 1,000             -          130,000
  Depreciation                        36,377             -           77,155
                                ------------  ------------   --------------
     Total expenses                  396,706             -        2,327,323
                                ------------  ------------   --------------

Other income (expense):
  (Loss) on debt settlement                -             -          (25,925)
  Interest income                        560             -            2,790
  Interest (expenses)                (10,823)            -          (33,643)
                                ------------  ------------   --------------

Net (loss)                      $   (406,469) $          -   $   (2,381,601)
                                ============  ============   ==============

Weighted average number of        82,503,026    17,789,500
common shares outstanding -     ============  ============
basic and fully diluted

Net (loss) per share -          $      (0.00) $          -
basic and fully diluted         ============  ============



The accompanying notes are an integral part of these financial statements.


/6/


                         CareDecision Corporation
                     [formerly ATR Search Corporation]
                       (a Development Stage Company)
                   Consolidated Statements of Cash Flows
                                (unaudited)


                                For the three months ended     July 6,2000
                                        March 31,            (inception) to
                                --------------------------      March 31,
                                    2003          2002            2003
                                ------------  ------------   --------------

Cash flows from operating
 activities
Net (loss)                      $   (406,469) $          -   $   (2,381,601)
Shares issued for services           231,000             -        1,550,482
Loss on debt settlement                    -             -           25,925
Depreciation                          36,377             -           77,155
Adjustments to reconcile net
 (loss) to net cash (used)
 by operating activities:
   (Increase) decrease in notes        1,912             -           (3,464)
    receivable
   Decrease in loan to officer        10,611             -             (388)
                                ------------  ------------   --------------
Net cash (used) by operating        (126,569)            -         (731,503)
 activities                     ------------  ------------   --------------


Cash flows from financing
 activities
   Proceeds from convertible notes    50,000             -           50,000
    - related party
   Proceeds from notes payable             -             -          476,035
   Proceeds from note payable to      46,500             -           46,500
    shareholder
   Issuance of common stock                -             -          240,000
                                ------------  ------------   --------------
Net cash provided by financing        96,500             -          812,535
 activities                     ------------  ------------   --------------

Net increase in cash                 (30,069)            -           81,032
Cash - beginning                     111,101             -                -
                                ------------  ------------   --------------
Cash - ending                   $     81,032  $          -   $       81,032
                                ============  ============   ==============

Supplemental disclosures:
   Interest paid                $          -  $          -   $            -
                                ============  ============   ==============
   Income taxes paid            $          -  $          -   $            -
                                ============  ============   ==============

Non-cash transactions:
   Number of shares issued for     5,500,000             -       25,117,737
    services provided           ============  ============   ==============

   Number of shares issued to      2,500,000             -        2,500,000
    acquire technology          ============  ============   ==============



The accompanying notes are an integral part of these financial statements.


/7/


                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)
                              Notes

Note 1 - Basis of presentation

The  consolidated  interim financial statements included  herein,
presented  in  accordance with United States  generally  accepted
accounting  principles  and  stated  in  US  dollars,  have  been
prepared by the Company, without audit, pursuant to the rules and
regulations  of the Securities and Exchange Commission.   Certain
information   and  footnote  disclosures  normally  included   in
financial   statements  prepared  in  accordance  with  generally
accepted  accounting  principles have been condensed  or  omitted
pursuant  to  such  rules and regulations, although  the  Company
believes   that  the  disclosures  are  adequate  to   make   the
information presented not misleading.

These  statements reflect all adjustments, consisting  of  normal
recurring  adjustments, which, in the opinion of management,  are
necessary  for  fair  presentation of the  information  contained
therein.   It  is  suggested  that  these  consolidated   interim
financial statements be read in conjunction with the consolidated
financial statements of the Company for the period ended December
31, 2001 and notes thereto included in the Company's Form 10-KSB.
The   Company  follows  the  same  accounting  policies  in   the
preparation of consolidated interim reports.

Results  of operations for the interim periods are not indicative
of annual results.

Note 2 - Going concern

The accompanying financial statements have been prepared assuming
that  the  Company  will  continue  as  a  going  concern,  which
contemplates the recoverability of assets and the satisfaction of
liabilities in the normal course of business. As noted above, the
Company is in the development stage and, accordingly, has not yet
generated  a  proven history of operations. Since its  inception,
the   Company   has  been  engaged  substantially  in   financing
activities and developing its product line, incurring substantial
costs and expenses. As a result, the Company incurred accumulated
net losses from July 6, 2000 (inception) through the period ended
March  31,  2003  of  $(2,381,601). In  addition,  the  Company's
development  activities  since inception  have  been  financially
sustained by capital contributions.

The  ability  of  the Company to continue as a going  concern  is
dependent upon its ability to raise additional capital  from  the
sale  of  common  stock  and,  ultimately,  the  achievement   of
significant   operating   results.  The  accompanying   financial
statements do not include any adjustments that might be  required
should  the Company be unable to recover the value of its  assets
or satisfy its liabilities.

Note 3 - Fixed assets

On   February  5,  2003,  the  Company  acquired  fully-developed
software  valued  at  $181,250  from  CareDecision.net,  Inc.,  a
corporation under common control as the Company.

Depreciation  expense totaled $36,377 for the three-month  period
ended March 31, 2003.

Note 4 - Notes payable - related party

During  the  three  months  ended March  31,  2003,  the  Company
received  loans  totaling $46,500 from a Company shareholder  and
director.   The notes bear interest at 9% per annum and  are  due
365 days from date of issuance.

During  the  three  months  ended March  31,  2003,  the  Company
recorded interest expense of $10,823.


/8/


                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)
                              Notes

Note 5 - Convertible notes

During  the  three  months  ended March  31,  2003,  the  Company
received a loan totaling $50,000 from a Company shareholder.  The
note is convertible into 1,538,500 shares of the Company's $0.001
par  value  common stock at a strike price of $0.0325 per  share.
The  convertible  note  also carried with it  1,538,500  warrants
exercisable on a one-for-one basis at a strike price  of  $0.0325
per  share.  On April 22, 2003, the holder elected to convert the
note  into  1,538,500 shares of the Company's  $0.001  par  value
common stock.

Note 6 - Stockholder's equity

The Company is authorized to issue 5,000,000 shares of $0.001 par
value  preferred stock and 200,000,000 shares of $0.001 par value
common stock.

During  the three months ended March 31, 2003, the Company issued
5,500,000  shares  of  $0.001  par  value  common  stock  to  two
individuals for consulting services valued at $231,000.

During  the three months ended March 31, 2003, the Company issued
2,500,000  shares  of $0.001 par value common  stock  to  acquire
developed software valued at $181,250 from CareDecision.net, Inc.

There have been no other issuances of preferred or common stock.

Note 7 - Related party transactions

During  the  three  months  ended March  31,  2003,  the  Company
acquired fully-developed software from CareDecision.net,  Inc,  a
private   corporation  with  common  ownership  as  the  Company.
Pursuant  to  the  agreement, the Company paid  CareDecision.net,
Inc.  the  sum of $182,500 with 2,500,000 shares of the Company's
$0.001 par value common stock.

During  the  three  months  ended March  31,  2003,  the  Company
received  $46,500  from  Robert Cox, a  Company  shareholder  and
Chairman  of  the  Board.  The notes are due  on  365  days  from
issuance and accrued interest at 9% per annum.

During  the  three  months  ended March  31,  2003,  the  Company
received $50,000 from Dr. Thomas Chillemi, a Company shareholder,
the  note  is convertible into 1,538,500 shares of the  Company's
$0.001  par  value  common stock and carries  with  it  1,538,500
warrants exercisable on a one-for-one basis at a strike price  at
$0.0325 per share.

Note 8 - Stock option plan

On  January  1, 2003, the Company adopted its "2003 Stock  Option
Plan"  (the "Plan") and granted incentive and nonqualified  stock
options  with  rights  to  purchase  25,000,000  shares  of   the
Company's  $0.001  par value common stock.   The  Company  issued
5,500,000  shares of stock pursuant to the plan during the  three
months ended March 31, 2003.

Note 9 - Subsequent events

On  May 5, 2003, the Company announced it has signed an agreement
with a third party hotel management company for the purchase  and
installation  of  the Company's proprietary ResidenceWare  multi-
unit  messaging  management system.  The agreement  specifies  an
immediate initial installation of 250 units at a minimum of  five
hotel locations.


/9/


                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)
                              Notes

Note  10  -  Reverse acquisitions agreement with  Medicius,  Inc.
(MED)

On  June 21, 2001, the Company entered into an agreement with MED
whereby  the  Company acquired all of the issued and  outstanding
common  stock of NDI in exchange for 38,043,863 voting shares  of
the Company's $0.001 par value common stock.  The acquisition was
accounted  for  using  the  purchase  method  of  accounting   as
applicable   to   reverse   acquisitions   because   the   former
stockholders  of  the MED controlled the Company's  common  stock
immediately  upon conclusion of the transaction.   Under  reverse
acquisition accounting, the post-acquisition entity was accounted
for  as  a recapitalization of MED.  The common stock issued  was
recorded  at $0, being the fair value of the Company's assets  on
the acquisition date.


/10/


      Item 2. Management's Discussion and Plan of Operation


Forward-Looking Statements

     This Quarterly Report contains forward-looking statements
about our business, financial condition and prospects that
reflect our assumptions and beliefs based on information
currently available.  We can give no assurance that the
expectations indicated by such forward-looking statements will be
realized.  If any of our assumptions should prove incorrect, or
if any of the risks and uncertainties underlying such
expectations should materialize, our actual results may differ
materially from those indicated by the forward-looking
statements.

     The key factors that are not within our control and that may
have a direct bearing on operating results include, but are not
limited to, acceptance of our services, our ability to expand our
customer base, our ability to raise capital in the future, the
retention of key employees and changes in the regulation of our
industry.  There may be other risks and circumstances that we are
unable to predict.  When used in this Quarterly Report, words
such as,  "believes,"  "expects,"  "intends,"  "plans,"
"anticipates,"  "estimates" and similar expressions are intended
to identify forward-looking statements, although there may be
certain forward-looking statements not accompanied by such
expressions.  All forward-looking statements are intended to be
covered by the safe harbor created by Section 21E of the
Securities Exchange Act of 1934.


General

     Our principal product is an E-Health handheld information
appliance software package.  We presently have a comprehensive
suite of medical information technology and Internet
communication applications, integrated for medical professional
use on a wireless PDA Internet appliance.  These applications
have been designed to meet the needs of both the inpatient and
outpatient medical environments and are not just commercially
viable but also regulatory standard compliant.  Additionally, our
software applications were conceived and implemented to offer the
medical professional the ability to monitor patient treatment
plans on the same handheld information appliance.

     Our software is designed to integrate point of care medical
applications, treatment protocols and up to the moment patient
histories coupled with real-time on-line medical insurance claims
submission.  Our ultimate key to success resides in providing the
private practice physician with the capability to, sequentially,
learn about the history of his or her patient during, or prior
to, entering the examining room, treat the patient and update the
insurer of the episode of care.  Accomplishing these objectives
resolves a major dilemma for the health care provider;
instantaneous communication of vital patient related information
at or before the patient encounter.

     Our technologies are grounded in the central need to furnish
the doctor with crucial point-of-care patient information rapidly
and reliably via a PDA.  It utilizes the power of the Internet to
move large amounts of data to and from a variety of platforms
securely via a powerful Windows CE based PDA designed for
portability and upgradability.  Totally compliant with the Health
Insurance Portability and Accountability Act of 1996 ("HIPAA"),
this PDA technology is among the first to offer complicated and
real-time point of care applications, previously legacy
(mainframe or PC network) system applications, on a totally
portable (PDA) appliance.


/11/


     Our PDA software operates on any Microsoft Windows CE
"Pocket PC" based handheld device, either in a wireless or
"wired" mode.  The local host for our PDA devices is a Windows
(9X, NT or later) based PC in the physician's office, which, in
turn, permits one to eight of the aforementioned PDAs to be
linked to the medical network and allows each PDA to become a
uniquely identified mobile node on the medical network,
independent of PC linkage, thereby, assisting the doctor in the
review of relevant patient medical history, medications and
prescriptions, lab test ordering, medical step processes and
protocols and specialist referral processes.

     The PDA software provides rules based software capabilities
and the ability to receive order fulfillment information for over
5,000 patients simultaneously, which represents approximately 3
years of patient encounters in a typical primary care medical
practice, and allows medical professionals to access payor and
health plan business rules, and policy/plan coverage's directly
from the plan(s).


Results of Operations

     The following is an itemization of our results of operations
for the three-month period ended March 31, 2003.  There are no
comparables for the three-month period ended March 31, 2002 as no
revenues were generated and no expenses incurred in that period.

REVENUES. Total revenues for the three-month period ended March
31, 2003 were $500.  As a development stage company we have yet
to generate significant revenues and we cannot guarantee with
certainty when we will begin to generate significant revenues.
Our future revenues will be reliant on the acceptance of our
software systems, communication tools and suite of software
applications.

GENERAL AND ADMINISTRATIVE. General and Administrative expenses
relate to the operation and leasing costs of our corporate
office.  General and administrative expenses for the three-month
period ended March 31, 2003 were $38,878.

PAYROLL. Payroll expense consists primarily of management and
employee salaries.  Total payroll expense for the three-month
period ended March 31, 2003 was $58,881.

PROFESSIONAL FEES. Professional fees include fees paid to our
accountants and attorneys.  Our professional fees were $30,570
for the three-month period ended March 31, 2003.

CONSULTING. Consulting expense includes fees paid to consultants
in relation to the preparation of required SEC filings, and to
individuals engaged to assist management in the furtherance of
our business plan.  Consulting expenses for the three-month
period ended March 31, 2003 were $231,000.

SOFTWARE DEVELOPMENT. Software Development cost was minimal as
our software systems; communication tools and suite of software
applications are complete.  Software Development expense for the
three-month period ended March 31, 2003 was $1,000.

DEPRECIATION. Depreciation was $36,377 for the three-month period
ended March 31, 2003.  This represents depreciation on the assets
of the Company.

TOTAL OPERATING EXPENSES. Total operating expenses for the three-
month period ended March 31, 2003 were $396,706.  Our most
significant operating expenses are consulting and payroll
expenses.


/12/


LOSS FROM OPERATIONS/NET LOSS. Our loss from operations was
$406,469 for the three-month period ended March 31, 2003.  It
should be expected that we will continue to incur losses from
operations until such time as revenues can be generated to cover
such costs.


Future Business

     The elements of our future business strategy include:
expanding geographically into key markets through a combination
of opening new offices and developing relationships with clients
to generate demand for our services; recruiting qualified,
medical software and other technical personnel to perform
technical, implementation and support duties as contracts are
entered into, although there can be no assurance that any such
contracts will be secured; and pursuing entry into new markets
complementary to our proposed operations.  Future operations are
dependent upon our ability to implement our business and
marketing strategies and to establish relationships and contracts
with health insurers and HMOs to provide our e-healthcare
products and services.


Liquidity and Capital Resources

     Management believes our cash on hand of $81,032 will not be
sufficient to fund ongoing fiscal 2003 and 2004 operations and
provide for our working capital needs given we have negative
working capital of $459,533.  Thus we will from time to time need
to raise additional funds through capital markets.  Our
accountant has issued a note concerning our ability to continue
as a going concern.  As we are still considered to be in the
development stage, our prospects of continuing as a going concern
are contingent upon our ability to raise additional capital and
to achieve and maintain profitable operations.  Revenues
generated over and above expenses will be used for further
development of our services, to provide financing for marketing
and promotion, to secure additional customers, equipment and
personnel, and for other working capital purposes.

     To date, we have financed our cash flow requirements through
an issuance of common stock and through the issuance of notes.
During the three months ended March 31, 2003, we received loans
totaling $46,500 from a Company shareholder and director.  The
notes bear interest at 9% per annum and are due 365 days from
date of issuance.  In addition, during the three months ended
March 31, 2003, we received a loan totaling $50,000 from a
Company shareholder.  The note is convertible into 1,538,500
shares of the Company's $0.001 par value common stock at a strike
price of $0.0325 per share.  The convertible note also carried
with it 1,538,500 warrants exercisable on a one-for-one basis at
a strike price of $0.0325 per share.  On April 22, 2003, the
holder elected to convert the note into 1,538,500 shares of the
Company's $0.001 par value common stock.

     During our normal course of business, we will experience net
negative cash flows from operations, pending receipt of revenues.
Further, we will be obtaining financing to fund operations
through additional common stock offerings, note issuances and
bank borrowings, to the extent available, or to obtain additional
financing to the extent necessary to augment our available cash
on hand.

     All investor inquiries should be directed via mail to Mr.
Robert Cox, President, CareDecision Corp.   2 Penn Plaza, 15th
Floor, Suite 1500-53, New York, New York 10121.


/13/


                   PART II - OTHER INFORMATION


     Item 6(a) - Exhibits



  Exhibit  Name and/or Identification of Exhibit
  Number

   3.1     Articles of Incorporation & By-Laws
                 (a) Articles of Incorporation of the Company
                 filed March 2, 2001.  Incorporated by
                 reference to the exhibits to the Company's
                 General Form For Registration Of Securities
                 Of Small Business Issuers on Form 10-SB,
                 previously filed with the Commission.

                 (b) Certificate of Amendment to the Articles
                 of Incorporation of the Company filed May 9,
                 2001.  Incorporated by reference to the
                 exhibits to the Company's General Form For
                 Registration Of Securities Of Small Business
                 Issuers on Form 10-SB, previously filed with
                 the Commission.

                 (c) Certificate of Amendment to the Articles
                 of Incorporation of the Company filed August
                 2, 2002.  Incorporated by reference to the
                 exhibits to the Company's June 30, 2002
                 Quarterly Report on Form 10-QSB, previously
                 filed with the Commission.

   3.2           By-Laws of the Company adopted March 16,
                 2001.  Incorporated by reference to the
                 exhibits to the Company's General Form For
                 Registration Of Securities Of Small Business
                 Issuers on Form 10-SB, previously filed with
                 the Commission.

  99.1           Certification under Section 906 of the
                 Sarbanes-Oxley Act (18 U.S.C. SECTION 1350)


     Item 6(b) - Reports Filed on Form 8-K

     For the quarter ended March 31, 2003 the Company did not
file any reports on Form 8-K with the Securities and Exchange
Commission.


/14/


                           SIGNATURES

Pursuant to the requirements of the Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.

                    CareDecision Corporation
-----------------------------------------------------------------
                          (Registrant)




Date: May 14, 2003
     -------------



By: /s/ Robert Cox
   ---------------
   Robert Cox
   President and CEO





Date: May 14, 2003
     -------------



By: /s/ Keith Berman
   -----------------
   Keith Berman
   Secretary and Treasurer/CFO


/15/


                          Attachment A
              Form of Certification for Form 10-QSB
                         CERTIFICATIONS

I, Robert Cox, President of CareDecision Corporation (the
"registrant"), certify that:

     1. I have reviewed this quarterly report on Form 10-QSB of
        CareDecision Corporation;

     2. Based on my knowledge, this quarterly report does not
        contain any untrue statement of a material fact or omit to state
        a material fact necessary to make the statements made, in light
        of the circumstances under which such statements were made, not
        misleading with respect to the period covered by this quarterly
        report;

     3. Based on my knowledge, the financial statements, and other
        financial information included in this quarterly report, fairly
        present in all material respects the financial condition, results
        of operations and cash flows of the registrant as of, and for,
        the periods presented in this quarterly report;

     4. The registrant's other certifying officers and I are
        responsible for establishing and maintaining disclosure controls
        and procedures (as defined in Exchange Act Rules 13a-14 and 15d-
        14) for the registrant and we have:

          a) designed such disclosure controls and procedures to ensure
             that material information relating to the registrant, including
             its consolidated subsidiaries, is made known to us by others
             within those entities, particularly during the period in which
             this quarterly report is being prepared;

          b) evaluated the effectiveness of the registrant's disclosure
             controls and procedures as of a date within 90 days prior to the
             filing date of this quarterly report (the "Evaluation Date"); and

          c) presented in this quarterly report our conclusions about the
             effectiveness of the disclosure controls and procedures based on
             our evaluation as of the Evaluation Date;

     5. The registrant's other certifying officers and I have
        disclosed, based on our most recent evaluation, to the
        registrant's auditors and the audit committee of
        registrant's board of directors (or persons performing
        the equivalent function):

          a) all significant deficiencies in the design or operation of
             internal controls which could adversely affect the registrant's
             ability to record, process, summarize and report financial data
             and have identified for the registrant's auditors any material
             weaknesses in internal controls; and

          b) any fraud, whether or not material, that involves
             management or other employees who have a
             significant role in the registrant's internal
             controls; and


/16/


     6. The registrant's other certifying officers and I have
        indicated in this quarterly report whether or not there
        were significant changes in internal controls or in other
        factors that could significantly affect internal controls
        subsequent to the date of our most recent evaluation,
        including any corrective actions with regard to
        significant deficiencies and material weaknesses.



Date: May 14, 2003
     -------------



/s/ Robert Cox
--------------
Robert Cox
President and CEO




I, Keith Berman, Treasurer and Secretary of CareDecision
Corporation (the "registrant"), certify that:

     1. I have reviewed this quarterly report on Form 10-QSB of
        CareDecision Corporation;

     2. Based on my knowledge, this quarterly report does not
        contain any untrue statement of a material fact or omit to state
        a material fact necessary to make the statements made, in light
        of the circumstances under which such statements were made, not
        misleading with respect to the period covered by this quarterly
        report;

     3. Based on my knowledge, the financial statements, and other
        financial information included in this quarterly report, fairly
        present in all material respects the financial condition, results
        of operations and cash flows of the registrant as of, and for,
        the periods presented in this quarterly report;

     4. The registrant's other certifying officers and I are
        responsible for establishing and maintaining disclosure controls
        and procedures (as defined in Exchange Act Rules 13a-14 and 15d-
        14) for the registrant and we have:

          a. designed such disclosure controls and procedures to ensure
             that material information relating to the registrant, including
             its consolidated subsidiaries, is made known to us by others
             within those entities, particularly during the period in which
             this quarterly report is being prepared;

          b. evaluated the effectiveness of the registrant's disclosure
             controls and procedures as of a date within 90 days prior to the
             filing date of this quarterly report (the "Evaluation Date"); and

          c. presented in this quarterly report our conclusions about the
             effectiveness of the disclosure controls and procedures based on
             our evaluation as of the Evaluation Date;

     5. The registrant's other certifying officers and I have
        disclosed, based on our most recent evaluation, to the
        registrant's auditors and the audit committee of
        registrant's board of directors (or persons performing
        the equivalent function):


/17/


          a) all significant deficiencies in the design or operation of
             internal controls which could adversely affect the registrant's
             ability to record, process, summarize and report financial data
             and have identified for the registrant's auditors any material
             weaknesses in internal controls; and

          b) any fraud, whether or not material, that involves
             management or other employees who have a
             significant role in the registrant's internal
             controls; and

     6. The registrant's other certifying officers and I have
        indicated in this quarterly report whether or not there
        were significant changes in internal controls or in other
        factors that could significantly affect internal controls
        subsequent to the date of our most recent evaluation,
        including any corrective actions with regard to
        significant deficiencies and material weaknesses.



Date: May 14, 2003
     -------------



/s/ Keith Berman
----------------
Keith Berman
Secretary and Treasurer/CFO


/18/